Online pain management program for breast cancer survivors
Evaluating an Online Interprofessional Chronic Pain Management Group for Survivors of Breast Cancer: A Feasibility Study of a Randomized Controlled Trial
This study is testing an online pain management program for breast cancer survivors to see if it helps them better manage their pain and improve their well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hamilton Health Sciences Corporation Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Hamilton, Ontario) |
| Trial ID | NCT06101849 on ClinicalTrials.gov |
What this trial studies
This research evaluates an online inter-professional pain management program designed for survivors of breast cancer. Participants will engage in a 6-week program consisting of weekly group sessions that focus on understanding cancer pain, exercises for pain management, and psychological coping strategies. The study aims to assess the effectiveness of this program in addressing pain management concerns and its feasibility for future multi-centre randomized controlled trials. Participants will complete questionnaires before and after the program to measure satisfaction and changes in pain-related outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who have been diagnosed with Stage 1-3 breast cancer and are experiencing bothersome persistent pain.
Not a fit: Patients with significant cognitive impairment, pre-existing non-cancer pain conditions, or severe emotional distress may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve pain management and quality of life for breast cancer survivors.
How similar studies have performed: While there is limited research on online pain management specifically for breast cancer survivors, similar approaches in pain management have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. diagnosis of Stage 1-3 breast cancer; 2. had surgical excision at least 3 months ago; 3. completed neoadjuvant/adjuvant chemotherapy and/or radiation treatment at least 4 months ago; 4. within 5 years post active cancer treatment; 5. persistent pain within the last 3 months that is bothersome; 6. medical clearance to participate in the intervention 7. over 18 years of age; 8. verbal fluency in English; 9. have access to internet and technology to participate in the online program. Patients currently receiving adjuvant endocrine therapy or molecularly targeted therapies or who have completed these therapies within the last 5 years are eligible to participate. Exclusion Criteria: * Participants will be excluded from the study if they: 1. demonstrate significant cognitive impairment as determined by the clinical judgment of the provider; 2. have a pre-existing non-cancer pain condition, 3. have severe emotional distress that interferes with group participation as determined by scores above 15 on the Patient Health Questionnaire-9.
Where this trial is running
Hamilton, Ontario
- Juravinski Cancer Centre — Hamilton, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Karen Zhang, PHD — Hamilton Health Sciences Corporation
- Study coordinator: Karen Zhang, PHD
- Email: zhangka@HHSC.CA
- Phone: 905.521.2100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.